Silexion Therapeutics SLXN
NASDAQ SLXN
$0.28 +0.00 (+0.61%)
At close: Oct 1, 2026 · 4:00 PM EDT

Silexion Therapeutics (SLXN) Other financing activities (2024)

Updated

Silexion Therapeutics (SLXN) recorded Other financing activities of $3.34 million in FY2024.

Analysis

Silexion Therapeutics (SLXN) Other financing activities (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Silexion Therapeutics 192,458.84 -19.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 3.34 Mn
API Access

Silexion Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=SLXN&period=max&api_key=YOUR_API_KEY